What life expectancy at birth means and how it is measured
Life expectancy at birth in the United States is a population-level summary of how long infants born in a given year are expected to live if current mortality patterns hold through their entire lives. It is not a prediction for any individual, but a statistical measure derived from age-specific death rates in a calendar year. In the US, provisional data from the National Center for Health Statistics (NCHS) show that life expectancy at birth reached 77.5 years in 2021, 76.8 years in 2022, and 77.5 years in 2023, reflecting recent declines and a partial rebound. Researchers compute it using period life tables, which summarize current mortality across all ages to produce a single, comparable metric that helps public health officials and policymakers track long-term population health.
Recent trends in US life expectancy at birth
The COVID-19 period and provisional 2023 data
Between 2019 and 2023, US life expectancy at birth fell from 78.8 years in 2019 to 77.5 years in 2021, then increased to 77.5 years in 2023 according to provisional NCHS estimates. During 2020 and 2021, COVID-19 became a leading cause of death and contributed substantially to an average three year decline in life expectancy, reversing multidecade gains. The increase in 2023 partly reflects a decline in age-adjusted death rates compared to 2022. However, substantial disparities persist by race, ethnicity, and geography, and the US continues to lag behind many high income countries.
| Year | Life expectancy at birth (years) | Notes |
|---|---|---|
| 2019 | 78.8 | Pre-pandemic baseline |
| 2020 | 77.0 | COVID-19 mortality increase |
| 2021 | 77.5 | Provisional NCHS data; COVID-19 impact remains evident |
| 2022 | 76.8 | Provisional NCHS data; low point in recent cycle |
| 2023 | 77.5 | Provisional NCHS data; partial rebound observed |
How US life expectancy compares to other high income countries
Compared with peer nations in the Organisation for Economic Co-operation and Development (OECD), life expectancy at birth in the US remains lower. In most recent comparable estimates, the US hovers near the bottom of the high income group, with several countries consistently above 80 years. These differences reflect a combination of factors including health system organization, social determinants of health, income inequality, and prevalence of chronic conditions. Even before the pandemic, the US had not been converging with top performing peers at the same pace, and the setbacks of 2020 and 2021 widened gaps further.
Key drivers of mortality and disparities in the US
Patterns by age, race, and geography
In the United States, mortality is concentrated at younger and middle ages relative to some peer countries, with unintentional injuries, heart disease, cancer, COVID-19, chronic lower respiratory diseases, and stroke among the leading causes of death. Disparities by race and ethnicity are pronounced: life expectancy at birth has historically been lower for Black and Hispanic populations relative to White populations, driven in part by unequal access to care, neighborhood conditions, and exposure to comorbidities. Rural areas also experience higher age-adjusted death rates. These differences mean aggregate US life expectancy at birth masks substantial variation across subgroups and regions.
Methodological context and limitations
Period versus cohort life expectancy
Life expectancy at birth reported by NCHS is a period measure, computed from observed mortality rates in a single year or a multiyear span. It assumes future mortality patterns will resemble those observed recently, which can overstate true cohort expectations when trends are changing rapidly. Period estimates are useful for international comparisons and monitoring long term shifts, but they do not capture improvements or deteriorations that occur after a birth cohort comes of age. Cohort life expectancy, which tracks a hypothetical group born in a specific year through their actual mortality experience, typically produces lower estimates when mortality risks decline over time, and is more complex to estimate and communicate.
What the numbers mean for public health and policy
Using life expectancy alongside other metrics
Life expectancy at birth is a concise, widely recognized indicator of population health, but it should be paired with complementary measures such as years of potential life lost, cause-specific mortality, and social determinants data to inform policy. Because it is a period measure, officials also monitor age-adjusted death rates, maternal mortality ratios, and disparities gaps to design targeted interventions. Improvements in areas like injury prevention, chronic disease management, and equitable access to care can meaningfully raise life expectancy at birth over time, but progress requires sustained investment in health infrastructure and social programs.